Berdagang Gilead GILD

Jual
 Beli

Gilead carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Gilead news

Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Berita Terkini

Tunjukkan lebih lagi
Sophia Claire 2025 Aug 27, 13:20

EU Eyes Tariff Removal on US Goods Amid Trade Deal Push

Noah Lee 2025 Aug 27, 09:20

Asian Markets Ease Gold ETF Restrictions Amid Geopolitical Uncertainty

Ava Grace 2025 Aug 27, 08:20

Russia's Economic Dilemma: Will the Ukraine War Push Towards Peace?

Ava Grace 2025 Aug 27, 07:20

Goldman Sachs Predicts Oil Prices to Plunge to $50s by 2026: Analyzing the Forecast

Noah Lee 2025 Aug 27, 06:20

Cryptocurrency in Venezuela: An Economic Lifeline Amidst Hyperinflation and Sanctions

Liam James 2025 Aug 27, 06:20

Cambricon Shares Surge Amidst AI Chip Demand

Emma Rose 2025 Aug 27, 05:20

US Tariffs on India: Economic Impact and Analysis

Liam James 2025 Aug 27, 03:20

Iran Nuclear Deal Talks Stall: UN Sanctions Revival Looms

Maklumat

Sebaran nilai

0.72

Spread (%)

0.6329 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran dibuka

Rabu

13:31 - 19:59

Isnin

13:31-19:59

Selasa

13:31-19:59

Khamis

13:31-19:59

Jumaat

13:31-19:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

141638467584

Saham Tertunggak

1240809984

Tarikh Pendapatan (Seterusnya)

2013-01-28

Hasil Div

2025-09-29

Tarikh Selepas Dividen

2025-09-15

Kadar dividen tahunan depan

3.16

Hasil dividen tahunan depan

0.0275

EPS

5.04

Ketahui lebih lanjut mengenai instrumen ini

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan

latest_education_articles

Tunjukkan lebih lagi
Trustpilot